Microdosing of LSD does not show efficacy in adults with ADHD

Microdosing of lysergic acid diethylamide (LSD) over a 6‐week period showed no significant benefits over placebo in reducing symptoms of attention‐deficit hyperactivity disorder (ADHD) in adults, a Phase 2A trial has found. Both the LSD and placebo groups experienced marked improvement, the investigators reported.

Publication Details

Journal
The Brown University Psychopharmacology Update
Published
2025-06-02
DOI
https://doi.org/10.1002/pu.31324
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microdosing of LSD does not show efficacy in adults with ADHD

The Brown University Psychopharmacology Update
Psychedelics and Drug Studies
article

Microdosing of LSD does not show efficacy in adults with ADHD

article en

Abstract

Microdosing of lysergic acid diethylamide (LSD) over a 6‐week period showed no significant benefits over placebo in reducing symptoms of attention‐deficit hyperactivity disorder (ADHD) in adults, a Phase 2A trial has found. Both the LSD and placebo groups experienced marked improvement, the investigators reported.

The Brown University Psychopharmacology UpdateVol. 36(7)
Openalex Percentile: Top 83%
Psychedelics and Drug Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Microdosing of LSD does not show efficacy in adults with ADHD · The Brown University Psychopharmacology Update (2025) | TGRS Research Map | TGRS